Asher Biotherapeutics Stock
Asher Bio is a biotechnology company developing precisely targeted immunotherapies for cancer and other diseases using their cis-targeting platform.
Sign up for SecondMarket™ to view the market and buy or sell Asher Biotherapeutics Stock
Buy + SellSee Asher Biotherapeutics Valuations + Financials
*Sample data + company shown for illustrative purposes only
Gain insights Into Asher Biotherapeutics Stock Valuation + Share Prices
View real-time Tape D™ data on Asher Biotherapeutics stock including most recent valuation and historical share price information.
Are you an institutional investor or employee shareholder? Sign up to the SecondMarket™ trading platform.
Get StartedAsher Biotherapeutics Management Team
Director
Reid Huber
CEO
Craig Gibbs, PhD, MBA
COO
Kyle Elrod
Founder, CTO
Andy Yeung
CEO
Craig Gibbs, PhD, MBA
Director
Jeffrey K. Tong
CEO
Craig Gibbs, PhD, MBA
Founder, CSO
Ivana Djuretic
Asher Biotherapeutics Major Investors
Logos Capital
Boxer Capital LLC
MBC BioLabs
Y Combinator
The Invus Group LLC
Marshall Wace LLP
Alexandria Venture Investments
Mission BioCapital
RA Capital Management LLC
Third Rock Ventures LLC
Wellington Management Company LLP
Learn More About Asher Biotherapeutics Stock
Buy Asher Biotherapeutics Stock
01Asher Biotherapeutics stock does not trade on public stock exchanges. Asher Biotherapeutics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Asher Biotherapeutics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Sell Asher Biotherapeutics Stock
02Asher Biotherapeutics Stock does not trade on public stock exchanges. In order to sell Asher Biotherapeutics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Asher Biotherapeutics Stock Price
03Asher Biotherapeutics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view Asher Biotherapeutics share price and other valuable private market data.
Read more about secondary market private company stock prices:
Asher Biotherapeutics Stock Ticker Symbol
04There is no ticker symbol for Asher Biotherapeutics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Criteria to Sell Asher Biotherapeutics Stock
05Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Asher Biotherapeutics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Criteria to Buy or Invest in Asher Biotherapeutics Stock
06Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Asher Biotherapeutics stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Asher Biotherapeutics Stock Settlement
07Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Asher Biotherapeutics IPO
08Asher Biotherapeutics is a private company and has not had an IPO. There is currently no Asher Biotherapeutics IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to Asher Biotherapeutics IPO.
Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.
Sign up for SecondMarket™ to view the market and buy or sell Asher Biotherapeutics Stock
Buy + Sell*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.